Strategic Partnerships Imago has existing collaboration momentum with MedAxiom, Mayo Clinic licensing and Acculab Life research partnership, indicating a sales pathway through top-tier medical institutions and industry partners.

Clinical Value The Imago ICE technology enhances visualization and characterization of diverse imaging modalities, offering improved diagnostic accuracy for cancer and cardiovascular diseases, which can be pitched to hospitals and imaging centers seeking better patient outcomes and cost management.

Regulatory & Adoption With reputable clinical advisory and presence at major conferences (TCT, LSI), there is evidence of clinical credibility and potential for larger hospital systems to adopt the platform through pilot programs and reference sites.

Financial Backing Recent SAFE funding rounds totaling several million signal investor confidence and potential for scale; leverage this for joint ventures, co-development deals, or customer financing options to close enterprise deals.

Market Expansion Diverse applications across radiology, mammography and cardiovascular imaging suggest cross-selling opportunities to multi-specialty providers and imaging centers looking to differentiate offerings and expand service lines.